3lines Venture Capital

3lines Venture Capital occupies an unusual structural niche in the early-stage venture landscape: it operates from Greenwood Village, Colorado, with an explicit corridor between the United States and India, focused on Series A enterprise technology investments where AI, healthcare, and applied technology overlap. The geography matters. Founders who are building companies that draw engineering or operational leverage from India while selling into United States enterprise customers, or that want a syndicate that can support either side of that corridor, will find 3lines unusually well-positioned. The firm engages with cross-border execution as a real operating discipline rather than a slide in a pitch deck.

The thesis covers digital health, medical devices and medtech, and Health IT, with AI explicitly identified as a focal area. The firm is comfortable underwriting AI risk and tends to back companies whose models are tied to a specific healthcare or industrial problem rather than horizontal applications. Within healthcare, 3lines pays particular attention to enterprise software with credible clinical or operational anchors, medtech companies whose path to scale is realistic on Series A capital, and Health IT plays where AI shifts the unit economics in a measurable way. The firm tends to enter at Series A, after a company has demonstrated initial product-market fit and is ready to scale go-to-market and engineering, which means founders should be prepared to discuss not only the technology but the operational rigor of how they intend to grow the team across geographies.

The input data does not enumerate specific portfolio companies, so founders should request the current portfolio during initial conversations. The publicly observable pattern is a concentration on Series A enterprise and applied technology companies with cross-border characteristics, often with founders who have meaningful operating experience in either the United States or India and intend to leverage both. Founders should expect 3lines to focus diligence on enterprise sales motion, customer references, and the realism of cross-border execution if it is part of the plan.

Check sizes typically fall in the one to five million dollar range at entry, with the firm operating at Series A. 3lines is willing to participate alongside larger leads or anchor smaller Series A rounds when conviction is strong. The reserve practice is consistent with a fund that intends to support companies through subsequent rounds, and founders should expect the firm to be a meaningful participant in follow-on financings if the company is on track. The stage focus is firmly Series A, which means pre-seed and seed founders should plan to come back later rather than try to fit the firm into an early round.

Decision-making is concentrated in the Colorado partnership, with deal sourcing and diligence support that draws on India-based operators and advisors. The firm operates with the cadence of an institutional Series A fund, and founders should expect a diligence process that takes time to build conviction across both technical and commercial dimensions.

The right approach is a warm introduction from a portfolio founder, an enterprise software operator, or a co-investor with shared history in cross-border deals. Cold outreach is read, particularly when the founder can articulate why their company benefits from a US-India syndicate and what the next twelve to eighteen months of execution look like. Founders should arrive with enterprise customer references, a clear go-to-market plan, and an honest read on the operational risks of building across geographies.

What founders should know is that 3lines is a fit for Series A founders building applied AI, healthcare, or enterprise technology companies with genuine cross-border characteristics. Founders building purely domestic consumer plays will find a less natural fit. Founders who want a thoughtful Series A partner with real experience operating across the United States and India will find 3lines one of the more credible firms in that specific niche.